País: Regne Unit
Idioma: anglès
Font: MHRA (Medicines & Healthcare Products Regulatory Agency)
Miconazole
Johnson & Johnson Ltd
A01AB09
Miconazole
20mg/1gram
Oromucosal gel
Oromucosal; Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 12030200; GTIN: 5012674021422
TOP miconazole _ SUGAR FREE_ _2% ORAL GEL_ ■ This medicine is used to treat fungal and bacterial infections of the mouth and throat. ■ This medicine is for use by adults, children and infants aged 4 months and over. ■ Do not take this medicine: ■ Some people should not use this medicine._ _To fi nd out if you are one of them _See Section 2 _ c ■ If you are allergic to the active substance, other similar antifungal medicines or any of the other ingredients of this medicine (listed in section 6) ■ Speak to your doctor: ■ If you suffer from any of the conditions mentioned in section 2. _See Section 2 _ c ■ If you are taking any other medicines. _See Section 2 _ c ■ Follow the dosage instructions carefully. Children of different ages and adults need different amounts. These are shown in the dosage table. _See Section 3 _ c ■ If you are giving the gel to a child or infant, ensure that the gel does not become a choking hazard by making sure you place the gel at the front of the mouth. _See Section 3 _ c Now read this whole leafl et carefully before you use this medicine. Keep the leafl et: you might need it again. 1 What the medicine is for Daktarin Sugar Free 2% Oral Gel is a medicine which is used to treat fungal and bacterial infections of the mouth and throat. The gel contains miconazole which works by destroying the fungus and associated bacteria which may be present. This medicine is for use in adults, children and infants aged 4 months and over. 2 Before using this medicine This medicine is suitable for most adults and children but a few people should not use it. If you are in any doubt, talk to your doctor or pharmacist. Do not use this medicine… ■ If you are allergic to the active substance, other similar antifungal medicines or any of the other ingredients of this medicine (listed in section 6) ■ If you suffer from liver dysfunction. ■ If it is for an infant under 4 months of age because of the risk of choking. ■ If you are taking any of the following medicines: ■ _Warfarin _(a Llegiu el document complet
OBJECT 1 DAKTARIN SUGAR FREE 2% ORAL GEL Summary of Product Characteristics Updated 08-Aug-2017 | McNeil Products Ltd 1. Name of the medicinal product DAKTARIN Sugar Free 2% Oral Gel 2. Qualitative and quantitative composition Each gram of Daktarin Sugar Free 2% Oral Gel contains 20 mg of miconazole. For a full list of excipients, see section 6.1. 3. Pharmaceutical form Oral gel. White gel with orange taste. 4. Clinical particulars 4.1 Therapeutic indications Oral treatment of fungal infections of the oropharynx and of superinfections due to Gram-positive bacteria in adults and paediatric patients 4 months and older (see _Contraindications_ and _Warnings and _ _Precautions_). 4.2 Posology and method of administration For oral administration. 1 measuring spoon (provided) is equivalent to 124 mg miconazole per 5mL gel. For topical treatment of the oropharynx. Infants: 4 – 24 months: 1.25 ml (¼ measuring spoon of gel) applied four times a day after meals. Each dose should be divided into smaller portions and the gel should be applied to the affected area(s) with a clean finger. The gel should not be applied to the back of the throat due to possible choking. The gel should not be swallowed immediately, but kept in the mouth as long as possible. Adults and children 2 years of age and older: 2.5 ml (½ measuring spoon of gel) applied four times a day after meals. The gel should not be swallowed immediately, but kept in the mouth as long as possible/. The treatment should be continued for at least a week after the symptoms have disappeared. For oral candidosis, dental prostheses should be removed at night and brushed with the gel. 4.3 Contraindications Hypersensitivity to the active substance(s), other imidazole derivatives or to any of the excipients listed in section 6.1. In infants less than 4 months of age or in those whose swallowing reflex is not sufficiently developed (see section 4.4). In patients with liver dysfunction. Coadministration of the following drugs that are subject to metabolism by CYP3A4 or CYP2C Llegiu el document complet